[Protective action of pralidoxime against the teratogenic effects of parathion on the axial skeleton of the quail embryo].
D000014:Abnormalities, Drug-Induced / Q000517:prevention & control*; D000818:Animals; D001842:Bone and Bones / Q000002:abnormalities*; D002801:Cholinesterase Reactivators / Q000627:therapeutic use*; D002802:Cholinesterases / Q000502:physiology; D004625:Embryo, Nonmammalian / Q000187:drug effects*; D009024:Morphogenesis / Q000187:drug effects; D010278:Parathion / Q000037:antagonists & inhibitors*; D011220:Pralidoxime Compounds / Q000627:therapeutic use*; D011784:Quail
D002801:Cholinesterase Reactivators; D011220:Pralidoxime Compounds; D010278:Parathion; D002802:Cholinesterases
Action protectrice de la pralidoxime vis-å des effets tetratogenes du parathion sur le squelette axial de l'embryon de Caille